Displaying 1 - 20 of 10426 results
Released Company Title Industry Topic
06 Dec 2019
07:33 CET
CELYAD Celyad reçoit 2,5 millions EUR supplémentaires de financement non-dilutif Biotechnology Other financial transaction
06 Dec 2019
07:33 CET
CELYAD Celyad Receives Additional €2.5 Million in Non-Dilutive Funding Biotechnology Other financial transaction
06 Dec 2019
07:00 CET
NYRSTAR Nyrstar: Publication of First Half 2019 Consolidated Accounts Nonferrous Metals Other subject
06 Dec 2019
07:00 CET
FAGRON Openbaarmaking van ontvangen kennisgevingen Medical Equipment Other subject
06 Dec 2019
07:00 CET
NYRSTAR Nyrstar: Publicatie van de eerste helft van 2019 Geconsolideerde rekeningen Nonferrous Metals Other subject
06 Dec 2019
07:00 CET
FAGRON Disclosure of received notifications Medical Equipment Other subject
05 Dec 2019
18:01 CET
ASIT ASIT biotech: Information on the Total Number of Voting Rights and Shares Biotechnology Share introduction and issues
05 Dec 2019
18:01 CET
ASIT ASIT biotech : Information sur le nombre total de droits de vote et d’actions Biotechnology Share introduction and issues
05 Dec 2019
16:55 CET
SHURGARD Shurgard obtains a building permit for a self-storage property in the Paris region (Corbeil-Essonnes) Real Estate Holding&Development Mergers, Acquiqitions, Transferts
05 Dec 2019
13:32 CET
QRF Qrf - Transparantiekennisgeving Vanmoerkerke Retail REITs Other subject
05 Dec 2019
07:51 CET
AEDIFICA Aedifica NV/SA: Aedifica increases the offer price on Hoivatilat shares to €16.00 per share and receives additional irrevocable undertakings, now in total representing approx. 47.4% Specialty REITs Other subject
04 Dec 2019
06:45 CET
GIMV Imcheck Therapeutics raises USD 53 million, Gimv increases its investment in the immuno-oncology space Specialty Finance Other subject
04 Dec 2019
06:45 CET
GIMV ImCheck Therapeutics erhält 53 Millionen US-Dollar bei Serie-B-Runde – Gimv erhöht Investments im Bereich Immunonkologie Specialty Finance Other subject
04 Dec 2019
06:45 CET
GIMV Imcheck Therapeutics haalt USD 53 miljoen op, Gimv verhoogt zijn investering voor de verdere ontwikkeling van immuno-oncologie therapieën Specialty Finance Other subject
04 Dec 2019
06:45 CET
GIMV Imcheck Therapeutics lève 53 millions de dollars, Gimv renforce son investissement dans le domaine de l\'immuno-oncologie Specialty Finance Other subject
03 Dec 2019
18:42 CET
IBA IBA SA - Update following capital increase dated 03 December 2019 Medical Equipment Change in Capital
03 Dec 2019
18:42 CET
IBA IBA SA - Mise à jour suivant l'augmentation de capital du 3 décembre 2019 Medical Equipment Change in Capital
03 Dec 2019
17:46 CET
CIE BOIS SAUVAGE ANNULATION D’ACTIONS PROPRES Specialty Finance Other subject
03 Dec 2019
17:46 CET
CIE BOIS SAUVAGE CANCELLATION OF OWN SHARES Specialty Finance Other subject
03 Dec 2019
17:46 CET
CIE BOIS SAUVAGE VERNIETIGING VAN EIGEN AANDELEN Specialty Finance Other subject